pharmaphorum
AUGUST 24, 2020
Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes? . With our understanding of cancer accelerating at an unprecedented rate, and personalised medicines on the cusp of becoming mainstream, regulatory bodies need new ways to assess products. .
Pharma Marketing Network
AUGUST 26, 2020
The pharmaceutical industry has been under pressure for the past decade to change its go-to-market models. While the industry has attempted change, any change to its approach has been guarded. But the industry’s new challenge—marketing and selling in a COVID-19 environment—abruptly changes the customer interaction landscape, perhaps permanently. In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the spor
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
AUGUST 26, 2020
The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.
Pharma Mirror
AUGUST 28, 2020
A CPAP machine is a device that can replace or improve human breathing, increase lung ventilation, and improve respiratory function. It is generally used for lung failure or airway obstruction to breathing normally to help the patient complete the breathing process of inhalation and exhalation. It has a variety of breathing modes (various ways in. The post What Is the Difference Between Oxygen Generators and CPAP?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
AUGUST 23, 2020
Normal. 0. false. false. false. EN-GB. X-NONE. X-NONE. A smartphone-based app that uses facial analysis technology to spot chronic pain in people with dementia, called PainChek, is being rolled out in the UK by its Australian developer. The artificial intelligence-powered tool can help care workers and clinicians to identify and manage pain in patients with conditions like Alzheimer’s disease that can make it difficult for them to communicate.
Pharma Tutor
AUGUST 27, 2020
About Author. Mohd Riyaz Beg1* 1. Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai. *Corresponding author’s. email: phm19mr.beg@pg.ictmumbai.edu.in; mohdriyazbeg@gmail.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Dr. Jamie Hardy: The Lifestyle Pharmacist
AUGUST 24, 2020
Omgeeeee #FABSQUAD ! Life BC (before COVID) was pretty different for me and my family. Our downtime was spent traveling to our favorite cities around the US at least monthly and enjoying an. international vacation every summer. On normal weekends we would gather together for food and fellowship at local restaurants or at my parent’s house. Fast forward 5 months.
pharmaphorum
AUGUST 26, 2020
Health insurer Humana has filed a lawsuit against telemedicine company QuivvyTech that it says resulted in fraudulent prescriptions worth millions of dollars being written for duped customers. According to the complaint, QuivvyTech hired telemarketers to cold-call Humana members, whose details were obtained using “illegal means,” and encouraged them to talk about common ailments, claiming to be calling from Humana.
Pharma Times
AUGUST 27, 2020
Blenrep is a first-line inhibitor of BCMA, a cell-surface protein that plays a crucial role in the survival of plasma cells and is expressed on multiple myeloma cells
Outsourcing Pharma
AUGUST 27, 2020
The clinical trials marketplace company reportedly is connecting sites with 10,000 patients a month, with 40% of them from non-white groups.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Med Ed 101
AUGUST 26, 2020
I can’t thank you all enough for the support and as always I like to provide some free resources (in addition to the blog and podcast) along the way! I’ve just recently released a free pharmacology course on Udemy.com. The general overview of the course is on pharmacodynamics and pharmacokinetics. I focused primarily on common […].
pharmaphorum
AUGUST 27, 2020
Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. The COVID-19 pandemic has brought about a radical transformation, with investors now eager to fund companies involved in the fight against the virus.
Pharma Mirror
AUGUST 26, 2020
Romaco Innojet has just developed the first mobile processing machine for pilot scale applications. The VENTILUS® Pilot represents an all-in-one solution both for laboratories and for manufacturers of small batch sizes. The system design with only one spray nozzle simplifies scale-up processes. Romaco Innojet has just launched the first mobile processing machine in the market.
Outsourcing Pharma
AUGUST 25, 2020
The company is joining with Zosano Pharma to aid the commercialization and distribution of Qtrypta, a transdermal migraine treatment candidate.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
AUGUST 23, 2020
Timolol is an effective medication for reducing intraocular pressure in patients with glaucoma. The recommended starting dose is one drop of timolol 0.25% ophthalmic solution in the affected eye(s) twice daily. It is a non-selective beta-blocker. Ophthalmic administration does not prevent systemic absorption and effects. In patients with significant hypotension, falls, or bradycardia of unknown […].
pharmaphorum
AUGUST 27, 2020
Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19. An analysis of the latest data from a phase 1 trial showed that in 20 older adults given the vaccine – ten between the ages of 56 and 70 and ten aged 71 and older – the vaccine produced neutralising antibodies and T-cells in comparable levels to those aged 18 to 55-years-old.
Pharma Times
AUGUST 26, 2020
In a pivotal Phase II/III study, twice as many patients receiving the drug achieved the primary endpoint of ASAS 40 response at week 14 versus placebo
Outsourcing Pharma
AUGUST 25, 2020
The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.
Druggist
AUGUST 27, 2020
Sore throat is a common condition usually caused by a viral infection, and less commonly by a bacterial infection. A sore throat usually lasts about one week. It is a self-limiting condition meaning it goes on its own without treatment. There is no treatment for a sore throat caused by a viral infection. Even when a sore throat is caused by a bacterial infection, in most cases, patients will get better without antibiotic treatment (NICE, 2018).
pharmaphorum
AUGUST 27, 2020
Already under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA is now being accused of a blunder that could render current supplies unusable. Bioindustry association MichBio says the FDA’s labelling requirements for COVID-19 convalescent plasma (CCP) – which were published alongside the emergency use authorisation – could lead to “hundreds, if not thousands, of in-date, ready to transfuse CCP units across the country being rendered unusable.”.
Pharma Times
AUGUST 27, 2020
It is hoped that the vaccine will generate protection not only against SARS-CoV-2, but also against new strains of coronavirus that may arise in the future
Outsourcing Pharma
AUGUST 24, 2020
The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery.
Druggist
AUGUST 22, 2020
Thrush (also known as candidiasis) is a common condition affecting mainly women; however, men can also get it. Thrush infection may affect the vagina (or penis in men) or mouth (oral thrush). The focus of this post is the treatment of vaginal thrush with creams and combination products, which are available from the pharmacies (including online chemists), supermarkets and other online retailers.
pharmaphorum
AUGUST 25, 2020
Bayer has taken a further stake in New York-based One Drop to support its plans to become a digital health business by developing new integrated care services for patients. The German pharmaceutical company will work with One Drop on digital health products that span multiple therapeutic areas, with Bayer citing oncology, cardiovascular diseases and women’s health as potential targets.
Pharma Times
AUGUST 27, 2020
NICE says the combination's cost-effectiveness estimate is higher than what is considered acceptable for NHS use
Outsourcing Pharma
AUGUST 27, 2020
The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.
pharmaphorum
AUGUST 25, 2020
For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and now, as pharma is experiencing its most intense period of change in decades, a new update seeks to bring the Code in line with the modern sector. With the new Code now in its consultation stage, we spoke to ABPI president Haseeb Ahmad to find out more about the key changes.
pharmaphorum
AUGUST 28, 2020
Amazon has launched a fitness band, app and subscription service – called Halo – that promises to look after both your body and mind. The e-commerce giant’s entry into the health wearables market combines monitoring of physical data such as activity levels, sleep patterns and body fat with artificial intelligence (AI) algorithms that listen for the emotion in a user’s voice.
pharmaphorum
AUGUST 28, 2020
The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. In The Medscape Professional Networks’ latest white paper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications , key opinion leaders and industry experts agree that in the post-pandemic world, even as lockdowns are lifted and restrictions relaxed, the emerging trends for an increase in digital communications will stay.
pharmaphorum
AUGUST 24, 2020
Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. The drugmaker is divesting Takeda Consumer Healthcare, which operates mainly in Japan, to private equity group Blackstone for 242 billion yen ($2.3 billion), with the deal expected to close in March of next year.
pharmaphorum
AUGUST 28, 2020
The world is awash with data, and while retailers and TV subscription services have perfected the art of collection and curation, public health has been trailing behind. But the advent of COVID-19 is proving to be something of a coming of age for digital epidemiology, which has been putting data from disparate sources to global use for the last 15 years.
pharmaphorum
AUGUST 27, 2020
W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year. The move will give Discern Health access to healthcare communications agency W2O ’s proprietary data models and tools, as well as its 1,400-person-strong multidisciplinary team – including data analysts, scientific strategists, branding experts, communications specialists and creatives.
pharmaphorum
AUGUST 24, 2020
With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech Forbius and its pipeline of drugs for cancer and fibrotic diseases. Since its foundation in 2011, privately-held Forbius has been working on drugs that inhibit TGF beta 1 and 3, two targets thought to play a role in protecting cancers from attack by the immune system and the development of fibrosis (scarring).
pharmaphorum
AUGUST 23, 2020
German pharmaceutical company Merck has appointed Thomas Möller as its new head of group communications. Most recently responsible for corporate communications, Möller has worked at Merck since 2017, when he joined as head of external communications. Prior to that he served as head of media relations at BASF and held various corporate communications positions in Germany, the US and Switzerland.
Expert insights. Personalized for you.
127 
Let's personalize your content